Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Aohai Biotechnology is a Chinese biotechnology company specializing in the research, development, and manufacturing of veterinary biological products. Based in Qingdao, the company focuses on high-quality vaccines and diagnostic reagents for livestock and poultry, particularly targeting major infectious diseases such as Classical Swine Fever and Porcine Reproductive and Respiratory Syndrome. Aohai Bio integrates advanced molecular biology research with large-scale production, operating GMP-certified facilities to serve the animal husbandry industry. The company maintains active collaborations with agricultural research institutes to advance animal health solutions and disease control in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Aohai Biotechnology.